We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Craneware Plc | LSE:CRW | London | Ordinary Share | GB00B2425G68 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -80.00 | -3.57% | 2,160.00 | 2,200.00 | 2,250.00 | 2,250.00 | 2,225.00 | 2,250.00 | 75,720 | 16:35:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Prepackaged Software | 174.02M | 9.23M | 0.2626 | 84.73 | 782.26M |
From Apr 2019 to Apr 2024
TIDMCRW
RNS Number : 9003G
Craneware plc
09 November 2018
Craneware plc
("Craneware" or the "Company")
Dividend Currency Election
09 November 2018 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 4 September 2018.
For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.31/GBP1.
For further information, please contact:
Craneware plc +44 (0)131 550 3100 Keith Neilson, CEO / Craig Preston, CFO Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900 Dan Webster/ George Sellar / Guy Pengelley Investec Bank (Joint Broker) +44 (0)20 7597 5970 Patrick Robb/ Sebastian Lawrence/ Henry Reast Alma (Financial PR) +44 (0)20 3405 0205 Caroline Forde/ Robyn Fisher/ Josh Royston
About Craneware
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
Learn more at www.craneware.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DIVEAPFNESFPFEF
(END) Dow Jones Newswires
November 09, 2018 03:55 ET (08:55 GMT)
1 Year Craneware Chart |
1 Month Craneware Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
